Category: Press Release

March 17, 2022

TFF Pharmaceuticals Enters into CRADA with the U.S. Army and The Geneva Foundation to Develop Dry Powder Needle-free Medical Countermeasures

Originally published by: TFF Pharmaceuticals New collaboration to study the use of Thin Film Freezing technology to formulate dry powder recombinant vaccine against SARS-CoV-2 for pulmonary delivery AUSTIN, Texas, March 17, 2022 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin

November 10, 2021

Jonas-Geneva Joint Doctoral Nursing Scholarship Recipient Announced

Jonas Nursing and Veterans Healthcare and The Geneva Foundation have awarded Stacy Dolan, RN the 2021-2023 cohort scholarship to advance veterans’ healthcare. NEW YORK, November 2021 – Jonas Nursing and Veterans Healthcare (Jonas) and The Geneva Foundation (Geneva) announce the recipient of the 2021-2023 cohort joint scholarship that funds doctoral nursing candidates seeking to improve

June 14, 2021

Geneva Advancing COVID-19 Research in NIH-Sponsored ACTIV-2 Clinical Trials

Geneva has been selected to support a monoclonal antibody protocol under this public-private partnership at two military treatment facilities. TACOMA, WA – The Geneva Foundation (Geneva) announces today it has entered into a Cooperative Research and Development Agreement (CRADA) to conduct clinical trials at two military treatment facilities under the Accelerating COVID-19 Therapeutic Interventions

May 20, 2021

Investigating a New Form of ADC to Treat Metastatic Breast Cancer

The Geneva Foundation is partnering with NCI scientists and the U.S. Army on two investigational grants for breast cancer research using novel antibody-drug conjugates. Geneva Principal Investigator Martin J. Schenermann, PhD, a senior investigator at the National Cancer Institute (NCI) and Principal Investigator Brad St. Croix, PhD, a senior scientist also at NCI, were each awarded

April 29, 2021

4D Bio³ Program Designated as a USU Center for Biotechnology by the Uniformed Services University

The USU-4DBio3 Center for Biotechnology, administered by The Geneva Foundation, ensures warfighters are supported by cutting-edge biotechnologies. BETHESDA, MD – The Geneva Foundation (Geneva) announces today the official designation of the Biotechnology, Biomanufacturing, and Bioprinting Program (4DBio3) as a Uniformed Services University (USU) Center. The USU-4DBio3 Center for Biotechnology, derived from the 4DBio3 Program and

February 9, 2021

Geneva Adds Four New Members to Scientific Advisory Board

Kent Kester, MD, is appointed as SAB Chair. The Geneva Foundation (Geneva) announces today the appointment of four new members to its Scientific Advisory Board (SAB) which provides scientific consult, advisement, and direction to Geneva’s senior leadership, program directors, principal investigators, and research administrators. “It is a great honor to take on the role

February 2, 2021

Geneva Announces Changes to Board of Directors

PREVIOUS GENEVA VICE CHAIR NEIL VINING, MD, MBA IS APPOINTED AS BOARD CHAIR. The Geneva Foundation (Geneva) announces changes to its Board of Directors with several new additions and the appointment of Dr. Neil Vining as Chair. The additions, and appointment of a new Chair, come as several long-serving members retired from the Board of Directors

December 29, 2020

Geneva ‘JBLM Grant’ Winners Advancing New Standard of Care for Trauma Victim Resuscitation

LTC (P) Matthew Eckert, MD and CAPT Daniel Lammers, MD will present their research findings at the 34th East Scientific Assembly. During acute trauma scenarios, medical personnel are in a battle with time as the challenge becomes: is there enough time to stop ongoing blood loss? Hemorrhage from major trauma is the leading cause of death

November 23, 2020

Geneva Announces Researcher of the Year Andriy Batchinsky, MD

Renowned lung injury Research Scientist Andriy Batchinsky, MD has been named The Geneva Foundation’s (Geneva) 2019 Researcher of the Year in recognition of his long-standing career pursuing ground-breaking treatments for the management of acute respiratory distress syndrome (ARDS), with notable contributions in research quality and research mentorship. Dr. Batchinsky is a principal investigator for Geneva and manager

October 27, 2020

USU-4D Bio3 Expands Facility to Accommodate On-Demand Blood Program

On-demand blood will enable military medical professionals the access to quality blood supplies from anywhere in the world. The Geneva Foundation (Geneva) announces today the expansion of the 4-Defense Biotechnology, Biomanufacturing and Bioprinting Center (4D Bio3) program, a federally-funded partnership based at the Uniformed Services University (USU) and administered by Geneva, with the addition of

1 2 3 4 Next